Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
NCT07322913 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2026-03-12
Summary
The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.
Conditions
- Carotid Artery Diseases
- Aortic Diseases
- Peripheral Arterial Diseases
Interventions
- DEVICE
-
Intergard Standard - Collagen Coated Vascular Grafts and Patches
Intergard Standard, Collagen coated vascular grafts and patches are made of knitted (knitted or knitted ultrathin) or woven polyester. The products are coated with a highly purified form of cross-linked bovine collagen to minimize intraoperative bleeding and eliminate the need for preclotting at the time of implant. Note that the radially supported grafts have a polypropylene supportive coil designed to resist kinking and compression of extra-anatomical vascular repair, where potential unwanted mechanical compression of the graft may occur.
- DEVICE
-
Hemashield - Collagen Coated Vascular Grafts and Patches
Hemashield Vascular Grafts and Patches are made of knitted or woven polyester. The products are impregnated with a highly purified bovine collagen to reduce bleeding at the time of implant and thereby eliminates the operative preclotting step.
- DEVICE
-
Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches
Intergard Silver antimicrobial collagen coated vascular grafts are made of knitted (knitted or knitted ultrathin) or woven polyester. The Hemapatch Silver Ultrathin is a surgical patch made from knitted ultrathin polyester fabric. The products are coated with a highly purified form of cross-linked bovine collagen to minimize intraoperative bleeding and eliminate the need for preclotting at the time of implant. In addition to collagen coating, the collagen matrix of Intergard Silver vascular grafts and patches is loaded with an antimicrobial agent: silver acetate. The coating of silver is designed to inhibit the microbial colonization on the device and within tissue immediately proximate to the device in the acute post-operative phase.
- DEVICE
-
Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
Intergard Synergy antimicrobial collagen coated vascular grafts are made of knitted (knitted or knitted ultrathin) polyester. The products are coated with a highly purified form of cross-linked bovine collagen to minimize intraoperative bleeding and eliminate the need for preclotting at the time of implant. In addition to collagen coating, the collagen matrix of Intergard Synergy Antimicrobial collagen coated vascular grafts is loaded with antimicrobial agents: silver acetate and triclosan. The addition of silver acetate and triclosan on collagen coated vascular products is designed to inhibit the microbial colonization on the device and in the surrounding tissues in the acute postoperative phase.
Sponsors & Collaborators
-
Intervascular
lead INDUSTRY
Principal Investigators
-
Director, Clinical Affairs · Getinge
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-19
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
- FDA Device
- Yes
Countries
- United States
- France
- Spain
Study Locations
More Related Trials
-
Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)
NCT00733135 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
NCT04201132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.
NCT00264043 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft
NCT01042444 ·Status: TERMINATED ·Phase: NA
-
The eSVS® Mesh Post-Marketing Trial
NCT01520311 ·Status: TERMINATED ·Phase: NA
-
Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna
NCT00705913 ·Status: TERMINATED ·Phase: NA
-
Cardiogenesis Transmyocardial Revascularization Registry
NCT01827319 ·Status: COMPLETED
-
Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system
NCT02011984 ·Status: UNKNOWN
-
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Thoraflex™ Hybrid Device for the Treatment of Aneurysm/dissection of the Descending Thoracic Aorta
NCT03735472 ·Status: COMPLETED
-
Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease
NCT07338890 ·Status: NOT_YET_RECRUITING
-
Prospective and Non-randomized Registry of CardioCel 3D
NCT04175327 ·Status: ACTIVE_NOT_RECRUITING
-
Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA
NCT00478673 ·Status: TERMINATED ·Phase: PHASE4
-
Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Aortic Aneurysms
NCT01168037 ·Status: COMPLETED
-
The VIRTUE Post Marketing Surveillance Registry
NCT01213589 ·Status: COMPLETED
-
Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation
NCT04459208 ·Status: COMPLETED ·Phase: NA
-
ACHIEVE GRX Registry
NCT04513613 ·Status: WITHDRAWN
-
Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
NCT01917682 ·Status: COMPLETED
-
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
NCT03103620 ·Status: COMPLETED
-
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
NCT00752128 ·Status: COMPLETED
-
Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
NCT01526811 ·Status: COMPLETED
-
Safety and Efficacy Evaluation of Orbital Atherectomy System in de Novo Calcified Lesions
NCT05417022 ·Status: RECRUITING
-
Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.
NCT02915328 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study
NCT02759406 ·Status: COMPLETED ·Phase: NA
-
MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization
NCT04271033 ·Status: RECRUITING ·Phase: NA